A cutting-edge view on the current state of antiviral drug development.
about
Cloak and Dagger: Alternative Immune Evasion and Modulation Strategies of PoxvirusesIntegrase Inhibitor Prodrugs: Approaches to Enhancing the Anti-HIV Activity of β-Diketo AcidsCurrent and future directions for treating hepatitis B virus infectionNovel approaches and challenges to treatment of central nervous system viral infectionsCompounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virusThe clinically approved antiviral drug sofosbuvir inhibits Zika virus replicationTherapeutic Potential of Spirooxindoles as Antiviral AgentsAdenovirus infections in immunocompetent and immunocompromised patients.Ebola hemorrhagic fever: current outbreak and progress in finding a cure.How to approach and treat viral infections in ICU patientsNelfinavir impairs glycosylation of herpes simplex virus 1 envelope proteins and blocks virus maturation3-O-galloylated procyanidins from Rumex acetosa L. inhibit the attachment of influenza A virus.Structural Analysis of Monomeric RNA-Dependent Polymerases: Evolutionary and Therapeutic ImplicationsThe acyclic nucleoside phosphonates (ANPs): Antonín Holý's legacy.Ebola virus outbreak, updates on current therapeutic strategies.The case of chronic hepatitis B treatment with tenofovir: an update for nephrologists.Letermovir Treatment of Human Cytomegalovirus Infection Antiinfective Agent.A Simple Platform for the Rapid Development of Antimicrobials.
P2860
Q26797325-F90FC78E-7BD9-4F3C-8C66-AB6509D04A6BQ26800036-7789C576-150A-4D37-8025-DF4F906FFB1FQ26851240-2DF3D3D5-E1C5-485A-A414-886426A06947Q26862449-80F3A1AE-687F-4882-8F1D-E0DF13701681Q28084005-2DA174D9-7112-4D8D-BC79-6F524807D9F7Q28595139-3D4AAA72-406E-4930-BF43-53E7FF94D0E1Q33637160-5852F9F8-EA02-4D59-8BE3-27A70A55586FQ34057627-CA05A473-B415-441C-B187-029FCD64AA30Q34491250-71CC3F2C-FF95-4E20-9E36-95A093021784Q34894660-17414539-3797-45B4-9EE8-8B5E0AAC369BQ35077455-5B8A9285-9EB0-49F4-AE6A-B84DA35591A8Q35321520-86E770CC-8B5D-4199-A842-BB3D58A5F127Q35784542-9D0C6505-4297-4703-A1C0-B1C6AC8549DEQ38097391-5545D159-8D61-40EC-83A5-7E8CDD0181F6Q38473251-D1ECF98D-2D04-4EB6-9AE8-815CEE27AE89Q38520954-D79C9306-73E2-4E5B-BE51-1CDED30DB5D1Q39325580-09A7EC81-3A5C-4BA7-B73C-2FFBB785847CQ47163592-A13F7B42-3BAC-499A-AF8B-0C9B586B0EAE
P2860
A cutting-edge view on the current state of antiviral drug development.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A cutting-edge view on the current state of antiviral drug development.
@ast
A cutting-edge view on the current state of antiviral drug development.
@en
A cutting-edge view on the current state of antiviral drug development.
@nl
type
label
A cutting-edge view on the current state of antiviral drug development.
@ast
A cutting-edge view on the current state of antiviral drug development.
@en
A cutting-edge view on the current state of antiviral drug development.
@nl
prefLabel
A cutting-edge view on the current state of antiviral drug development.
@ast
A cutting-edge view on the current state of antiviral drug development.
@en
A cutting-edge view on the current state of antiviral drug development.
@nl
P2860
P356
P1476
A cutting-edge view on the current state of antiviral drug development.
@en
P2860
P304
P356
10.1002/MED.21281
P577
2013-03-11T00:00:00Z